The global laparoscopic gynecological procedures market accounted for USD 26.21 billion in 2023 and is expected to reach at USD 57.60 billion by 2034 with a CAGR of 7.42% during the forecast period 2024-2034. Rising acceptance of minimally invasive surgical techniques, increase in the prevalence of gynecological conditions such as uterine fibroids (UF), abnormal vaginal bleeding, ovarian cysts, cervical cancer, & endometriosis, growing advancements in surgical technologies, surge in the prevalence of uterine & colorectal cancers, uptick in laparoscopic procedures, growing preference for single-incision laparoscopic surgery, rising aging population, and increasing launch of innovative devices for laparoscopic gynecological procedures are some of the key factors boosting the market growth.
Increasing launch of innovative devices for laparoscopic gynecological procedures is predicted to boost the market growth during the forecast period. Laparoscopic gynecological procedures employ minimally invasive surgical methods for the diagnosis and treatment of diverse gynecological issues. Rather than employing a sizable incision, surgeons conduct these procedures through small keyhole incisions in the abdomen using a laparoscope, a slender, flexible tube equipped with a camera and light source. For instance, in May 2023, B. Braun introduces its latest laparoscopic AESCULAP EinsteinVision 3.0 FI at the International Society for Gynecologic Endoscopy (ISGE) Annual Meeting 2023 in Sanur, Bali.
By procedure, laparoscopic hysterectomy was the highest revenue-grossing segment in the global laparoscopic gynecological procedures market in 2023 owing to the increasing preference for minimally invasive procedures to remove the uterus is driven by several benefits, including decreased risks of blood loss and infection, as well as shorter hospital stays, and growing partnerships among market participants. For instance, in October 2023, Hologic, Inc., a renowned leader in women's health globally, has recently forged a groundbreaking partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical. Under this collaboration, Hologic will serve as the primary supplier of hysteroscopes for AAGL's Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) program, offering hands-on hysteroscopy skills training for OB-GYN residents. Additionally, laparoscopic myomectomy is predicted to grow at the fastest CAGR during the forecast period owing to the growing preference among gynecologists for laparoscopic methods, advancements in surgical tools and suturing materials, and rising utilization of robotic & laparoscopic-assisted surgeries to deliver high-quality and efficient healthcare.
By end-user, hospitals was the highest revenue-grossing segment in the global laparoscopic gynecological procedures market in 2023 owing to the rising reimbursements for specific procedures, aiming to enhance patient care quality, surge in hospitals' adoption of advanced technologies, increase in overall surgical procedures, and growing introduction of advanced medical devices. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech subsidiary, unveiled an AI-driven Surgical Simulation Platform at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. This innovative technology marks a significant advancement in surgical training, utilizing artificial intelligence (AI) and augmented reality (AR) for trainings, providing real-time data, and offering tactical feedback to enhance the skills of current and future surgeons. Additionally, ASCs is predicted to grow at the fastest CAGR during the forecast period owing to a strong preference for outpatient surgeries, rise in the utilization of minimally invasive surgical procedures, the cost-effectiveness of laparoscopic procedures performed in ambulatory surgery centers (ASCs), and an uptick in the number of patients with diverse chronic conditions.
North America region is anticipated for the highest revenue share during the forecast period owing to the existence of robust healthcare infrastructure, increased introduction of cutting-edge products, heightened awareness regarding the advantages of minimally invasive surgeries & laparoscopic procedures, and growing emphasis on expansion efforts by industry stakeholders. For instance, in January 2022, Microline Surgical has launched a fresh sales team in the Southeastern region to enhance the distribution of its products throughout the United States. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in acquisitions among market players, growing elderly population, escalating healthcare spending, advancements in surgical & other technological fields, increased government efforts to enhance healthcare services, and surge in initiatives by industry players to introduce innovative programs. For instance, in April 2022, Paras HMRI Hospital Patna has launched a pioneering program centered around Advanced Laparoscopic Surgery. The facility prides itself on its state-of-the-art equipment and advanced facilities tailored specifically for laparoscopic procedures.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Increasing launch of innovative devices for laparoscopic gynecological procedures is predicted to boost the market growth during the forecast period. Laparoscopic gynecological procedures employ minimally invasive surgical methods for the diagnosis and treatment of diverse gynecological issues. Rather than employing a sizable incision, surgeons conduct these procedures through small keyhole incisions in the abdomen using a laparoscope, a slender, flexible tube equipped with a camera and light source. For instance, in May 2023, B. Braun introduces its latest laparoscopic AESCULAP EinsteinVision 3.0 FI at the International Society for Gynecologic Endoscopy (ISGE) Annual Meeting 2023 in Sanur, Bali.
By procedure, laparoscopic hysterectomy was the highest revenue-grossing segment in the global laparoscopic gynecological procedures market in 2023 owing to the increasing preference for minimally invasive procedures to remove the uterus is driven by several benefits, including decreased risks of blood loss and infection, as well as shorter hospital stays, and growing partnerships among market participants. For instance, in October 2023, Hologic, Inc., a renowned leader in women's health globally, has recently forged a groundbreaking partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical. Under this collaboration, Hologic will serve as the primary supplier of hysteroscopes for AAGL's Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) program, offering hands-on hysteroscopy skills training for OB-GYN residents. Additionally, laparoscopic myomectomy is predicted to grow at the fastest CAGR during the forecast period owing to the growing preference among gynecologists for laparoscopic methods, advancements in surgical tools and suturing materials, and rising utilization of robotic & laparoscopic-assisted surgeries to deliver high-quality and efficient healthcare.
By end-user, hospitals was the highest revenue-grossing segment in the global laparoscopic gynecological procedures market in 2023 owing to the rising reimbursements for specific procedures, aiming to enhance patient care quality, surge in hospitals' adoption of advanced technologies, increase in overall surgical procedures, and growing introduction of advanced medical devices. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech subsidiary, unveiled an AI-driven Surgical Simulation Platform at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. This innovative technology marks a significant advancement in surgical training, utilizing artificial intelligence (AI) and augmented reality (AR) for trainings, providing real-time data, and offering tactical feedback to enhance the skills of current and future surgeons. Additionally, ASCs is predicted to grow at the fastest CAGR during the forecast period owing to a strong preference for outpatient surgeries, rise in the utilization of minimally invasive surgical procedures, the cost-effectiveness of laparoscopic procedures performed in ambulatory surgery centers (ASCs), and an uptick in the number of patients with diverse chronic conditions.
North America region is anticipated for the highest revenue share during the forecast period owing to the existence of robust healthcare infrastructure, increased introduction of cutting-edge products, heightened awareness regarding the advantages of minimally invasive surgeries & laparoscopic procedures, and growing emphasis on expansion efforts by industry stakeholders. For instance, in January 2022, Microline Surgical has launched a fresh sales team in the Southeastern region to enhance the distribution of its products throughout the United States. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in acquisitions among market players, growing elderly population, escalating healthcare spending, advancements in surgical & other technological fields, increased government efforts to enhance healthcare services, and surge in initiatives by industry players to introduce innovative programs. For instance, in April 2022, Paras HMRI Hospital Patna has launched a pioneering program centered around Advanced Laparoscopic Surgery. The facility prides itself on its state-of-the-art equipment and advanced facilities tailored specifically for laparoscopic procedures.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Procedure and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Laparoscopic Gynecological Procedures Market Report 2023 - 2034
Laparoscopic Gynecological Procedures Market Analysis & Forecast by Procedure 2023 - 2034 (Revenue USD Bn)
- Laparoscopic Myomectomy
- Laparoscopic Hysterectomy
- Laparoscopic Endometrial Excision
- Laparoscopic Adnexal
- Oophorectomy
- SalpingoOophorectomy
- Others
- Laparoscopic Colpopexy
- Sacrocolpopexy
- Sacrocervicopexy
- Other
- Laparoscopic Diagnostic Procedures
- Requiring Chromopertubation
Laparoscopic Gynecological Procedures Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Clinics
- Hospitals
- Ambulatory Surgery Centers (ASCs)
Laparoscopic Gynecological Procedures Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Laparoscopic Gynecological Procedures Market: Procedure Estimates & Trend Analysis
8. Laparoscopic Gynecological Procedures Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Laparoscopic Gynecological Procedures Market
11. Europe Global Laparoscopic Gynecological Procedures Market
12. Asia Pacific Global Laparoscopic Gynecological Procedures Market
13. Latin America Global Laparoscopic Gynecological Procedures Market
14. MEA Global Laparoscopic Gynecological Procedures Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Richard Wolf GmbH
- Stryker
- CONMED Corporation
- Olympus Corporation
- Johnson and Johnson
- B. Braun SE
- Microline Surgical
- Intuitive Surgical
- Medtronic
- The Cooper Companies Inc.
- Karl Storz SE & CO. Kg
- Welfare Medical Ltd.
- Shenzhen Mindray Bio Medical Electronics Co. Ltd.
